$40.21
-0.75-1.83%
At Close: -
$40.21
00.00%
After Hours: 1:04 PM EDT
15 minutes delayed
Ultragenyx Pharmaceutical
RARENASDAQ
Ultragenyx Pharmaceutical (RARE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestUltragenyx Pharmaceutical (NASDAQ:RARE) Stock Quotes, Forecast and News Summary
Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.
| Open | $40.82 |
| Close | $40.21 |
| Volume / Avg. | 638.26K / 886.56K |
| Day Range | 40.00 - 40.82 |
| 52 Wk Range | 31.52 - 54.56 |
| Market Cap | $3.64B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 6.4% |
| Days to Cover | 4.54 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Ultragenyx Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, dev...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ultragenyx Pharmaceutical (RARE) stock?
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Who are Ultragenyx Pharmaceutical (RARE) competitors?
Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the target price for Ultragenyx Pharmaceutical (RARE) stock?
There is no analysis for Ultragenyx Pharmaceutical.
What is the forecast for Ultragenyx Pharmaceutical (RARE) stock?
Ultragenyx Pharmaceutical has a consensus price target of $92.88.
Current stock price for Ultragenyx Pharmaceutical (RARE)?
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $40.21 last updated July 3, 2024 at 1:04 PM EDT.
Does Ultragenyx Pharmaceutical (RARE) pay a dividend?
There are no upcoming dividends for Ultragenyx Pharmaceutical.
When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?
Ultragenyx Pharmaceutical’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Ultragenyx Pharmaceutical (RARE) going to split?
There is no upcoming split for Ultragenyx Pharmaceutical.
What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.